{"entity":{"id":"nct05984810","kind":"trial","name":"NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101","aka":["FLUOPANC-II"],"tldr":"A phase 2 trial in pancreatic cancer, run by Leiden University Medical Center, now recruiting.","summary":"NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101 is a phase 2, interventional study registered as NCT05984810 by Leiden University Medical Center, with a registry enrolment figure of 20 participants, started 2024-03-18 and due to reach its primary completion in 2026-12. Interventions recorded: Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101. Conditions listed: Pancreas Adenocarcinoma. Primary outcome: Intra-operative visualization of neoadjuvant treated pancreatic tumors using Near-infrared fluorescence imaging,. Pancreatic eligibility wording from the registry: \"Neoadjuvant treated (borderline) resectable or locally advanced pancreatic cancer scheduled for a surgical resection\". Sites: Netherlands. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05984810","url":"https://clinicaltrials.gov/study/NCT05984810"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["borderline-resectable-pdac","resectable-pdac","locally-advanced-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05984810","phase":"2","setting":"A Performance Study of SGM-101, a Fluorochrome-labeled Anti-carcinoembryonic Antigen Monoclonal Antibody for Fluorescence-guided Imaging to Determine Local Extent and Resectability During Surgical Resection of Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment","sponsor":"Leiden University Medical Center","enrolled":20,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05984810/","neighbours":{"cancer":[{"id":"borderline-resectable-pdac","kind":"cancer","name":"Borderline resectable pancreatic ductal adenocarcinoma","route":"/cancers/borderline-resectable-pdac/"},{"id":"locally-advanced-pdac","kind":"cancer","name":"Locally advanced unresectable pancreatic ductal adenocarcinoma","route":"/cancers/locally-advanced-pdac/"},{"id":"resectable-pdac","kind":"cancer","name":"Resectable pancreatic ductal adenocarcinoma","route":"/cancers/resectable-pdac/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}